Table 1 Patient/tumor characteristics
Characteristics | Total (%) | CRT (%) | RT (%) | p Value |
|---|---|---|---|---|
Sex | 0.008 | |||
Male | 153 (77.7) | 76 (86.4) | 77 (70.6) | |
Female | 44 (22.3) | 12 (13.6) | 32 (29.4) | |
Age (years) | 0.028 | |||
≤65 | 73 (37.3) | 40 (45.5) | 33 (30.3) | |
>65 | 124 (62.7) | 48 (54.5) | 76 (69.7) | |
KPS | 0.141 | |||
≥80 | 114 (57.9) | 56 (63.6) | 58 (53.2) | |
70 | 83 (42.1) | 32 (36.4) | 51 (46.8) | |
The length | 0.358 | |||
≤5 cm | 182 (92.4) | 83 (94.3) | 99 (90.8) | |
>5 cm | 15 (7.6) | 5 (5.7) | 10 (9.2) | |
Tumor location | 0.092 | |||
Type I | 9 (4.6) | 4 (4.5) | 5 (4.6) | |
Type II | 95 (48.2) | 35 (36.8) | 60 (55.0) | |
Type III | 93 (47.2) | 49 (55.7) | 44 (40.4) | |
T stage | 0.002 | |||
T2 | 36 (18.3) | 8 (9.1) | 28 (25.7) | |
T3 | 68 (34.5) | 31 (35.2) | 37 (33.9) | |
T4 | 93 (47.2) | 49 (55.7) | 44 (40.4) | |
N stage | <0.0001 | |||
N0 | 49 (24.9) | 9 (10.2) | 40 (36.7) | |
N1 | 148 (75.1) | 79 (89.8) | 69 (63.3) | |
6th AJCC stage | <0.0001 | |||
II | 46 (23.4) | 9 (10.2) | 37 (33.9) | |
III | 151 (76.6) | 79 (89.8) | 72 (66.1) | |
Total dose | 0.235 | |||
≤70 | 67 (34.0) | 26 (29.5) | 41 (37.6%) | |
>70 | 130 (66.0) | 62 (70.5) | 68 (62.4) |